Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension

Our study evaluated whether there were differences in the prevalence of white-coat hypertension (WH) and masked hypertension (MH) based on the 2018 ESC/ESH and 2017 ACC/AHA hypertension guidelines in Korea. The motivation was the lowering of the diagnostic threshold for hypertension in the 2017 ACC/...

Full description

Bibliographic Details
Main Authors: Byong-Kyu Kim, Moo-Yong Rhee
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Healthcare
Subjects:
Online Access:https://www.mdpi.com/2227-9032/8/2/122
_version_ 1797568887279058944
author Byong-Kyu Kim
Moo-Yong Rhee
author_facet Byong-Kyu Kim
Moo-Yong Rhee
author_sort Byong-Kyu Kim
collection DOAJ
description Our study evaluated whether there were differences in the prevalence of white-coat hypertension (WH) and masked hypertension (MH) based on the 2018 ESC/ESH and 2017 ACC/AHA hypertension guidelines in Korea. The motivation was the lowering of the diagnostic threshold for hypertension in the 2017 ACC/AHA guidelines. Of 319 participants without antihypertensive drug history and with suspected hypertension based on outpatient clinic blood pressure (BP) measured by physicians, 263 participants (51.6 ± 9.6 years; 125 men) who had valid research-grade office BP and 24-h ambulatory BP measurements were enrolled. WH prevalence based on daytime ambulatory BP among normotensive individuals was lower with the ESC/ESH guidelines than the ACC/AHA guidelines (29.0% vs. 71.4%, <i>p</i> < 0.001). However, MH prevalence based on daytime ambulatory BP among hypertensive individuals was higher based on the ESC/ESH guidelines (21.6% vs. 1.8%, <i>p</i> < 0.001). Seventy percent of WH cases (2017 ACC/AHA guidelines) and 95.2% of MH cases (2018 ESC/ESH guidelines) occurred in individuals with systolic BP of 130–139 mmHg and/or diastolic BP of 80–89 mmHg. The diagnostic threshold of the 2017 ACC/AHA guidelines yielded a higher prevalence of WH compared to that of the 2018 ESC/ESH guidelines. However, the prevalence of MH was higher with the 2018 ESC/ESH guidelines than with the 2017 ACC/AHA guidelines. The high prevalence of WH and MH in people with a systolic BP of 130–139 mmHg or diastolic BP of 80–89 mmHg suggests the need for a more active out-of-office BP measurement in this patient group.
first_indexed 2024-03-10T20:03:13Z
format Article
id doaj.art-2c6805ac26ed4226a7d485d675fe1f36
institution Directory Open Access Journal
issn 2227-9032
language English
last_indexed 2024-03-10T20:03:13Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Healthcare
spelling doaj.art-2c6805ac26ed4226a7d485d675fe1f362023-11-19T23:24:17ZengMDPI AGHealthcare2227-90322020-05-018212210.3390/healthcare8020122Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked HypertensionByong-Kyu Kim0Moo-Yong Rhee1Division of Cardiology, Department of Internal Medicine, Dongguk University College of Medicine, Gyeongju Hospital, Gyeongju 38067, KoreaCardiovascular Center, Dongguk University Ilsan Hospital, 27 Dongguk-ro, Ilsandong-gu, Goyang-si, Gyeonggi 10326, KoreaOur study evaluated whether there were differences in the prevalence of white-coat hypertension (WH) and masked hypertension (MH) based on the 2018 ESC/ESH and 2017 ACC/AHA hypertension guidelines in Korea. The motivation was the lowering of the diagnostic threshold for hypertension in the 2017 ACC/AHA guidelines. Of 319 participants without antihypertensive drug history and with suspected hypertension based on outpatient clinic blood pressure (BP) measured by physicians, 263 participants (51.6 ± 9.6 years; 125 men) who had valid research-grade office BP and 24-h ambulatory BP measurements were enrolled. WH prevalence based on daytime ambulatory BP among normotensive individuals was lower with the ESC/ESH guidelines than the ACC/AHA guidelines (29.0% vs. 71.4%, <i>p</i> < 0.001). However, MH prevalence based on daytime ambulatory BP among hypertensive individuals was higher based on the ESC/ESH guidelines (21.6% vs. 1.8%, <i>p</i> < 0.001). Seventy percent of WH cases (2017 ACC/AHA guidelines) and 95.2% of MH cases (2018 ESC/ESH guidelines) occurred in individuals with systolic BP of 130–139 mmHg and/or diastolic BP of 80–89 mmHg. The diagnostic threshold of the 2017 ACC/AHA guidelines yielded a higher prevalence of WH compared to that of the 2018 ESC/ESH guidelines. However, the prevalence of MH was higher with the 2018 ESC/ESH guidelines than with the 2017 ACC/AHA guidelines. The high prevalence of WH and MH in people with a systolic BP of 130–139 mmHg or diastolic BP of 80–89 mmHg suggests the need for a more active out-of-office BP measurement in this patient group.https://www.mdpi.com/2227-9032/8/2/122hypertensionguidelineswhite coat hypertensionmasked hypertensionambulatory blood pressure
spellingShingle Byong-Kyu Kim
Moo-Yong Rhee
Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
Healthcare
hypertension
guidelines
white coat hypertension
masked hypertension
ambulatory blood pressure
title Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
title_full Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
title_fullStr Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
title_full_unstemmed Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
title_short Impact of 2018 ESC/ESH and 2017 ACC/AHA Hypertension Guidelines: Difference in Prevalence of White-Coat and Masked Hypertension
title_sort impact of 2018 esc esh and 2017 acc aha hypertension guidelines difference in prevalence of white coat and masked hypertension
topic hypertension
guidelines
white coat hypertension
masked hypertension
ambulatory blood pressure
url https://www.mdpi.com/2227-9032/8/2/122
work_keys_str_mv AT byongkyukim impactof2018esceshand2017accahahypertensionguidelinesdifferenceinprevalenceofwhitecoatandmaskedhypertension
AT mooyongrhee impactof2018esceshand2017accahahypertensionguidelinesdifferenceinprevalenceofwhitecoatandmaskedhypertension